Tag: Lord Hunt of Kings Heath

The below Parliamentary question was asked by Lord Hunt of Kings Heath on 2016-03-21.

To ask Her Majesty’s Government what priority they give to the elimination of hepatitis C as a threat to public health.

Lord Prior of Brampton

The United Kingdom Government takes the issue of prevention, diagnosis and treatment of hepatitis C very seriously. Public Health England (PHE) and NHS England continue working together with key stakeholders to establish a strategic approach to tackle hepatitis C, including monitoring treatment access and uptake, as well as establishing Operation Delivery Networks (ODNs).

NHS England has invested in a Commissioning for Quality and Innovation scheme to incentivise ODNs to meet their agreed rate of roll-out. If their treatment rates deviate from this agreed rate of treatment, they are no longer eligible for these incentives.

PHE is working together with NHS England and the National Offender Management Service to improve coverage of blood borne virus testing for people in prisons through implementation of opt-out testing.

PHE has also commissioned the Royal College of General Practitioners (RCGP) Certificate in the Detection, Diagnosis and Management of Hepatitis B and C in Primary Care to help raise awareness in primary care and among other professionals working with groups at high risk of chronic viral hepatitis infection. To supplement this, a new RCGP course was launched in April 2015, Hepatitis C: Enhancing Prevention, Testing and Care which comprises four lessons: understanding hepatitis C; preventing transmission; testing and diagnosis; and treatment and care.

The below Parliamentary question was asked by Lord Hunt of Kings Heath on 2016-04-14.

To ask Her Majesty’s Government what mitigating actions they propose to take with regards to the new contract for doctors in training in the light of the equality analysis undertaken under section 149 of the Equality Act 2010 showing that certain features of that contract will have an adverse impact on those who work part-time, who are predominantly women.

Lord Prior of Brampton

The contract published on 31 March is a huge step forward for achieving fairness for all trainee doctors. For the first time junior doctors will be paid and rewarded solely on the basis of their own hard work and achievement and pay progression will be linked to level of training rather than arbitrarily to time served.

All junior doctors should have the same terms and conditions – a level playing field – which is ultimately what employers and the British Medical Association (BMA) want and everyone deserves.

When the Secretary of State published the Equality Analysis on the new contract for doctors and dentists in training in the NHS (“Doctors”) on the 31 March 2016 on the GOV.UK website he made it clear that, as a result of considering the Equality Analysis, in accordance with his duties and obligations, he had asked for a number of changes to the draft contract to address specific issues for certain groups with protected characteristics. This has been done and the contract has been duly amended. These changes included changes that benefited staff who work part time. The new contract is not discriminatory it ensures that all junior doctors receive equal pay for work of equal value. The BMA’s own lawyers have advised that nothing in the new contract is discriminatory. Nevertheless the equality duty is an ongoing duty and it is intended that monitoring will continue after the introduction of the new contract in accordance with the public sector equality duty in the Equality Act 2010.

A copy of the Equality Analysis is attached.

The below Parliamentary question was asked by Lord Hunt of Kings Heath on 2016-04-25.

To ask Her Majesty’s Government under which legislative provision the Secretary of State has the power to impose junior doctors’ contracts on (1) GP practices that are not public bodies and deliver services to patients under a General Medical Services contract; (2) GP practices that are not public bodies and deliver services to patients under an Alternative Personal Medical Services contract; (3) local authorities that employ junior doctors to deliver public health services; and (4) NHS Trusts otherwise than by way of directions.

Lord Prior of Brampton

In deciding that a new contract – which would be safer for patients and fair and reasonable for junior doctors – should be introduced without further negotiation with the British Medical Association, the Secretary of State was exercising his powers under the NHS Act 2006 (in particular sections 1, 1A, 1B, 1F, 1G and 2). To introduce the contract he is working with the National Health Service and other employers who, as they are employers of junior doctors, are using their employment powers. The Secretary of State has not announced, and does not state, that he has a power to direct all NHS bodies or non-NHS bodies providing healthcare services.

The below Parliamentary question was asked by Lord Hunt of Kings Heath on 2016-05-04.

To ask Her Majesty’s Government what role local authorities will play in the development of Sustainability and Transformation Plans other than through membership of Health and Wellbeing Boards.

Lord Prior of Brampton

The NHS Planning Guidance, published in December 2015, explained that the success of Sustainability and Transformation Plans will depend on having an open, engaging, and iterative process that harnesses the energies of clinicians, patients, carers, citizens, local authorities, health and wellbeing boards, and local community partners. Local authorities should be fully engaged in the development of all Sustainability and Transformation Plans. In some cases, local National Health Service organisations have agreed with local authorities that a senior council leader will lead the Sustainability and Transformation Plan for their area.

The below Parliamentary question was asked by Lord Hunt of Kings Heath on 2016-05-18.

To ask Her Majesty’s Government what action they are taking to ensure that NICE guidance is followed in the use of faecal microbiota transplants in the treatment of recurrent Clostridium difficile infections.

Lord Prior of Brampton

The National Institute for Health and Care Excellence has produced guidance on faecal microbiota transplant for recurrent Clostridium difficile infection under the interventional procedure programme. This programme makes recommendations about the safety of the procedures and how well they work. However the guidance does not constitute a direction to National Health Service trusts to provide the interventions. Decisions about whether to provide a treatment are taken locally.

The below Parliamentary question was asked by Lord Hunt of Kings Heath on 2016-06-10.

To ask Her Majesty’s Government whether they plan to reduce the number of nurse advisers in the Department of Health.

Lord Prior of Brampton

As part of the DH2020 plan, the Department is making significant changes to the way it works. The underlying principles informing the changes include that the Department should focus on its core and unique functions to improve the health and care system in England to help people to live better for longer.

The Department’s approach is to flexibly access professional advice from a wide range of sources, including arms-length bodies, regulators and professional bodies, rather than from fixed standing teams of internal advisers.

These changes do not affect the role of the Chief Nursing Officer (CNO), who as the CNO of the Department already advises, and will continue to advise, all Ministers and the Department on the range of nursing issues.

The below Parliamentary question was asked by Lord Hunt of Kings Heath on 2016-09-05.

To ask Her Majesty’s Government what assessment they have made of the reasons for the Basildon Clinical Commissioning Group spending less than the national average on mental health services, according to NHS Benchmarking figures.

Lord Prior of Brampton

No such assessment has been made by this Department. NHS England advises that the National Health Service benchmarking data for 2014/15 (the latest data available) shows that, compared to a demographically similar cluster of clinical commissioning groups (CCGs), Basildon and Brentwood CCG spends slightly more than the cluster average on mental health services (£13,499,988 per 100,000 population against £13,080,187) and is therefore not considered an outlier. This analysis of the benchmarking data is used because within the CCG cluster the prevalence of mental health conditions, and therefore the appropriate spending, is likely to be comparable.

The below Parliamentary question was asked by Lord Hunt of Kings Heath on 2015-11-09.

To ask Her Majesty’s Government what discussions they have had with other EU member states concerning the impact on NHS patients of the introduction of the European Professional Card for healthcare professionals.

Lord Prior of Brampton

The aim of the European Professional Card (EPC) is to simplify and streamline the recognition of professional qualifications process for the applicant. Improving the freedom of movement of professionals will give the National Health Service greater access to a range of skills to the benefit of patients.

For health and care professions, the EPC will be introduced for nurses, pharmacists and physiotherapists in 2016. It will not be introduced for doctors until 2018 at the earliest. The EPC will be introduced through an Implementing Act.

The Department was involved in extensive negotiations with the European Commission and other Member States during the development of the Implementing Act and was successful in achieving a number of positive changes including increasing access to translations of documents, and ensuring that authorities can challenge the issuance of an EPC in another Member State under ‘justifiable circumstances’, which will be an important patient safety mechanism. We will continue to work with the health and care regulators and the Commission during the implementation process to mitigate any risks.

The United Kingdom was also successful in receiving a commitment from the Commission that they will undertake an early review to ensure that any issues are resolved before the EPC is rolled out to any additional professions.

The below Parliamentary question was asked by Lord Hunt of Kings Heath on 2015-11-19.

To ask Her Majesty’s Government whether the Medicines and Healthcare products Regulatory Agency can license the drug bevacizumab in the treatment of age-related macular degeneration in the absence of an application by the company that holds the patent.

Lord Prior of Brampton

The Medicines and Healthcare products Regulatory Agency (MHRA), an executive agency of the Department of Health, is responsible for the licensing of medicines. The MHRA is only able to assess and grant a licence for a particular use of a medicine once an application has been made and supporting data have been submitted to demonstrate that the quality, safety and efficacy of the medicine are satisfactory for the intended use.

The below Parliamentary question was asked by Lord Hunt of Kings Heath on 2015-12-01.

To ask Her Majesty’s Government what action they are taking to ensure that the Brighton and Sussex University Hospitals NHS Trust deals effectively with the issues of racial discrimination and harassment identified by the Care Quality Commission.

Lord Prior of Brampton

The NHS Trust Development Authority (TDA) is monitoring and working closely with Brighton and Sussex University Hospitals NHS Trust to support the Trust to address these issues.

We are advised by the TDA that the Trust’s Race Equality Workforce Engagement Strategy involves multiple work streams led by area specific engagement groups to address specific issues and challenges across all areas and levels of the Trust. It was launched at the joint Black and Minority Ethnic (BME) Network and Trust conference in October 2014.

A programme board was established and the first meeting was in February 2015. Programme board meetings are co-chaired by the Chief Executive and the Chair of the BME Network in order to provide oversight, performance management and governance of the race equality action plans developed by the various engagement groups.

We are assured by the TDA that the Trust followed procedures correctly in appointing the Chairman of the Trust to hear a right of appeal from nine BME members of staff against the decision of Henrietta Hill QC.